| Sep 30 |
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology
|
| Sep 17 |
Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors
|
| Sep 10 |
Kura Oncology to Participate in Cantor Global Healthcare Conference
|
| Sep 5 |
Kura Oncology, Inc. (KURA): This Small-Cap Healthcare Stock Is A Good Buy Right Now
|
| Aug 12 |
Kura Oncology: The Long Holding Pattern Is Risky
|
| Aug 9 |
Kura Oncology, Inc. (KURA) Q2 2024 Earnings Call Transcript
|
| Aug 8 |
Kura Oncology: Q2 Earnings Snapshot
|
| Aug 8 |
Kura Oncology GAAP EPS of -$0.59 beats by $0.04
|
| Aug 8 |
Kura Oncology Reports Second Quarter 2024 Financial Results
|
| Aug 8 |
FDA clears Kura to begin Phase 1 study of ziiftomenib for GIST
|
